Aristoforin, a Novel Stable Derivative of Hyperforin, Is a Potent Anticancer Agent
- 7 January 2005
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 6 (1) , 171-177
- https://doi.org/10.1002/cbic.200400195
Abstract
Hyperforin, a natural product of St. John's wort (Hypericum perforatum L.), has a number of pharmacological activities, including antidepressive and antibacterial properties. Furthermore, hyperforin has pronounced antitumor properties against different tumor cell lines, both in vitro and in vivo. Despite being a promising novel anticancer agent, the poor solubility and stability of hyperforin in aqueous solution limits its potential clinical application. In this study, we present the synthesis of hyperforin derivatives with improved pharmacological activity. The synthesized compounds were tested for their solubility and stability properties. They were also investigated for their antitumor properties, both in vitro and in vivo. One of these hyperforin derivatives, Aristoforin, is more soluble in aqueous solution than hyperforin and is additionally highly stable. Importantly, it retains the antitumor properties of the parental compound without inducing toxicity in experimental animals. These data strongly suggest that Aristoforin has potential as an anticancer drug.Keywords
This publication has 17 references indexed in Scilit:
- 2.1 Å Crystal Structure of Human PXR in Complex with the St. John's Wort Compound Hyperforin,Biochemistry, 2003
- Biosynthesis of Hyperforin in Hypericum perforatumJournal of Medicinal Chemistry, 2002
- Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosisOncogene, 2002
- St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical propertiesJournal of Pharmacy and Pharmacology, 2001
- St John's wort, a herbal antidepressant, activates the steroid X receptorJournal of Endocrinology, 2000
- Furohyperforin, a Prenylated Phloroglucinol from St. John's Wort (Hypericum perforatum)Journal of Natural Products, 1999
- Hyperforin, Possibly the Major Non-Nitrogenous Secondary Metabolite of Hypericum perforatum L.Pharmacopsychiatry, 1998
- Analysis and Stability of Hyperici OleumPlanta Medica, 1992
- Pathogenesis and characteristics of spontaneously metastasizing mammary carcinomas and the general principle of metastasisJournal of Surgical Oncology, 1986
- The structure of hyperforinTetrahedron Letters, 1975